SEP 26, 2019 1:30 PM PDT

Identification of Novel Biomarkers for Early Diagnosis and Prognosis of Melanoma

Presented at: Cell Biology 2019
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor of Clinical Dermatology and Pathology, UC Davis
    Biography
      Dr. Maija Kiuru is a dual board-certified practicing dermatologist and dermatopathologist and a physician-scientist at University of California, Davis. Dr. Kiuru received her MD degree and PhD in medical genetics from the University of Helsinki, Finland. Her thesis on hereditary leiomyomatosis and renal cell cancer (HLRCC) established the association between aggressive renal cell carcinoma, uterine fibroids, and cutaneous leiomyomas and identified the predisposing germline mutation in FH gene. She continued her research training as a postdoctoral fellow at Weill Cornell Medical College and Columbia University in New York. This research culminated in the discovery of PLCD1 mutations in hereditary leukonychia, revealing a new gene in nail biology, and identifying novel stem cell therapies for hereditary skin blistering disorders. Dr. Kiuru received her clinical training in dermatology and dermatopathology at Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center in New York.

      Dr. Kiuru's research focuses on genetics of familial skin disorders and cutaneous tumors. As a practicing dermatopathologists and dermatologist, one of her aims include identification of molecular markers of early melanomagenesis to improve diagnostic accuracy of melanocytic tumors. She is the recipient of NIH K23 and NIH K12 Career Development Awards, and the Dermatology Foundation Career Development Award in Dermatopathology. Dr. Kiuru has published numerous peer-reviewed articles, review articles, and book chapters, including in journals such as Nature Genetics, Nature Reviews Cancer, PNAS, Cancer Research, Cell Stem Cell, and American Journal of Human Genetics, and has lectured at many national and international meetings.

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 26, 2019 1:30 PM PDT

    Identification of Novel Biomarkers for Early Diagnosis and Prognosis of Melanoma

    Presented at: Cell Biology 2019
    C.E. Credits: P.A.C.E. CE Florida CE

    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources